Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Oct-10 8:20 PM View:  | Steel Partners, Ltd. 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Oct-10 | Market Purchase | 68,000 | $0.25 | $17,340.00 | 2% 3.5M to 3.57M | 48% |
| 29-Oct-10 8:20 PM View: | Steel Partners, Ltd. 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Oct-10 | Private Purchase | 125,000 | $0.25 | $31,875.00 | 4% 3.38M to 3.5M | |
| 02-Dec-09 3:37 PM View: | Gabrielson Mark J Chief Executive Officer Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 30-Nov-09 | Market Purchase | 2,000 | $0.62 | $1,240.00 | 17% 12.0K to 14.0K | (37%) |
| 01-Dec-09 12:47 PM View: | Fordyce James W Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Nov-09 | Market Purchase | 2,000 | $0.55 | $1,100.00 | 25% 8.0K to 10.0K | (29%) |
| 25-Nov-09 12:07 PM View: | Fordyce James W Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 25-Nov-09 | Market Purchase | 2,000 | $0.57 | $1,150.00 | 33% 6.0K to 8.0K | (32%) |
| 25-Nov-09 12:07 PM View: | Fordyce James W Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 23-Nov-09 | Market Purchase | 2,000 | $0.57 | $1,150.00 | 50% 4.0K to 6.0K | (32%) |
| 23-Nov-09 11:40 AM View: | Fordyce James W Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 20-Nov-09 | Market Purchase | 2,000 | $0.64 | $1,280.00 | 100% 2.0K to 4.0K | (39%) |
| 23-Nov-09 11:47 AM View: | Gabrielson Mark J Chief Executive Officer Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 18-Nov-09 | Market Purchase | 2,000 | $0.64 | $1,279.60 | 25% 8.0K to 10.0K | (40%) |
| 20-Nov-09 10:48 AM View: | Fordyce James W Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 18-Nov-09 | Market Purchase | 2,000 | $0.63 | $1,266.93 | 100% 0 to 2.0K | (39%) |
| 23-Nov-09 11:47 AM View: | Gabrielson Mark J Chief Executive Officer Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 17-Nov-09 | Market Purchase | 2,000 | $0.62 | $1,240.00 | 33% 6.0K to 8.0K | (37%) |
| 28-Aug-09 4:19 PM View: | Gabrielson Mark J Chief Executive Officer Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Aug-09 | Market Purchase | 2,000 | $0.58 | $1,160.00 | 50% 4.0K to 6.0K | (32%) |
| 19-Aug-09 1:44 PM View: | Gabrielson Mark J Chief Executive Officer Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 18-Aug-09 | Market Purchase | 2,000 | $0.60 | $1,190.00 | 100% 2.0K to 4.0K | (34%) |
| 24-Mar-08 5:29 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 21-Mar-08 | Grant | 50,000 | $1.37 | $68,500.00 | 25% 202.49K to 252.49K | (61%) |
| 18-Mar-08 7:38 PM View: | Miller Lloyd I III | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Mar-08 | Purchase | 1,375,760 | $0.71 | $975,417.00 | 30% 4.6M to 5.98M | (31%) |
| 18-Mar-08 7:38 PM View: | Miller Lloyd I III | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Mar-08 | Disposition | 2,267,420 | $0.71 | $1,607,600.00 | (38%) 5.98M to 3.71M | 31% |
| 18-Mar-08 7:38 PM View: | Miller Lloyd I III | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Mar-08 | Private Sale | 1,375,760 | $0.71 | $975,417.00 | (100%) 1.38M to 0 | 31% |
| 18-Mar-08 7:38 PM View: | Miller Lloyd I III | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Mar-08 | Disposition | 2,334,710 | $0.71 | $1,655,310.00 | (63%) 3.71M to 1.38M | 31% |
| 18-Dec-07 3:18 PM View: | Staples F Dudley Jr Senior VP, Secretary | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Dec-07 | Grant | 15,484 | -- | -- | 516% 3.0K to 18.48K | |
| 18-Dec-07 3:20 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 14-Dec-07 | Grant | 25,000 | -- | -- | 14% 177.49K to 202.49K | |
| 30-Nov-07 2:27 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 30-Nov-07 | Market Purchase | 32,000 | $0.94 | $30,206.20 | 22% 145.49K to 177.49K | (72%) |
| 29-Nov-07 4:48 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 29-Nov-07 | Market Purchase | 25,800 | $0.92 | $23,644.60 | 22% 119.69K to 145.49K | (71%) |
| 29-Nov-07 12:21 PM View: | Gabrielson Mark J Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Nov-07 | Market Purchase | 10,000 | $0.94 | $9,374.00 | 100% 0 to 10.0K | (72%) |
| 29-Nov-07 4:48 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Nov-07 | Market Purchase | 9,885 | $0.88 | $8,698.80 | 9% 109.81K to 119.69K | (70%) |
| 29-Nov-07 1:49 PM View: | Miller Lloyd I III Director 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Nov-07 | Market Purchase | 50,000 | $0.90 | $45,000.00 | 1% 4.55M to 4.6M | (71%) |
| 28-Nov-07 12:36 PM View: | Urdal David Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Nov-07 | Market Purchase | 25,000 | $0.90 | $22,500.00 | 100% 0 to 25.0K | (71%) |
| 27-Nov-07 1:59 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Nov-07 | Market Purchase | 30,000 | $0.84 | $25,332.70 | 38% 79.81K to 109.81K | (69%) |
| 29-Nov-07 1:49 PM View: | Miller Lloyd I III Director 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Nov-07 | Market Purchase | 11,440 | $0.84 | $9,651.00 | < 1% 4.54M to 4.55M | (69%) |
| 27-Nov-07 1:59 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 26-Nov-07 | Market Purchase | 10,908 | $0.82 | $8,989.39 | 16% 68.9K to 79.81K | (68%) |
| 28-Nov-07 12:28 PM View: | Gorry G Anthony Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 26-Nov-07 | Market Purchase | 15,000 | $0.84 | $12,642.30 | 214% 7.0K to 22.0K | (69%) |
| 27-Nov-07 1:28 PM View: | Thompson J Stark Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 26-Nov-07 | Market Purchase | 7,000 | $0.82 | $5,768.00 | 70% 10.0K to 17.0K | (68%) |
| 27-Nov-07 1:59 PM View: | Dimmler Charles L III CEO & President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 23-Nov-07 | Market Purchase | 30,000 | $0.79 | $23,723.60 | 77% 38.9K to 68.9K | (67%) |
| 01-Mar-07 10:03 AM View: | Dimmler Charles L III Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Feb-07 | Market Purchase | 5,000 | $1.81 | $9,050.00 | 15% 33.9K to 38.9K | (85%) |
| 02-Mar-07 3:21 PM View: | Brennan Michael J Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Feb-07 | Market Purchase | 51,119 | $1.80 | $92,014.20 | 19% 269.65K to 320.77K | (85%) |
| 02-Mar-07 3:23 PM View: | Gessler Mark D CEO and President Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 28-Feb-07 | Market Purchase | 51,119 | $1.80 | $92,014.20 | 26% 196.52K to 247.64K | (85%) |
| 27-Feb-07 12:11 PM View: | Thompson J Stark Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Feb-07 | Market Purchase | 2,800 | $1.76 | $4,928.00 | 39% 7.2K to 10.0K | (85%) |
| 01-Mar-07 10:03 AM View: | Dimmler Charles L III Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 27-Feb-07 | Market Purchase | 10,000 | $1.82 | $18,200.00 | 42% 23.9K to 33.9K | (86%) |
| 26-Feb-07 3:45 PM View: | Tartaglia Louis A SVP & GM Drug Repositioning | Ore Pharmaceutical Holdings... (ORXE.PK) | 22-Feb-07 | Grant | 60,471 | -- | -- | 100% 0 to 60.47K | |
| 31-Jan-07 11:40 AM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 30-Jan-07 | Market Purchase | 10,670 | $1.55 | $16,538.50 | < 1% 4.53M to 4.54M | (83%) |
| 30-Jan-07 3:56 PM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 29-Jan-07 | Market Purchase | 575,206 | $1.59 | $914,386.00 | 15% 3.95M to 4.53M | (83%) |
| 29-Jan-07 3:04 PM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 26-Jan-07 | Market Purchase | 10,312 | $1.52 | $15,674.20 | < 1% 3.94M to 3.95M | (83%) |
| 26-Jan-07 11:20 AM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 25-Jan-07 | Market Purchase | 7,768 | $1.52 | $11,807.40 | < 1% 3.94M to 3.94M | (83%) |
| 04-Dec-06 3:52 PM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 01-Dec-06 | Market Purchase | 1,200 | $1.40 | $1,680.00 | < 1% 3.94M to 3.94M | (81%) |
| 27-Nov-06 3:02 PM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 22-Nov-06 | Market Purchase | 15,089 | $1.40 | $21,124.60 | < 1% 3.92M to 3.94M | (81%) |
| 22-Nov-06 12:41 PM View: | Miller Lloyd I III 10% Owner | Ore Pharmaceutical Holdings... (ORXE.PK) | 21-Nov-06 | Market Purchase | 38,053 | $1.40 | $53,268.20 | < 1% 3.88M to 3.92M | (81%) |
| 04-Nov-05 5:03 PM View: | Dimmler Charles L III Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 04-Nov-05 | Market Purchase | 5,000 | $3.95 | $19,737.00 | 100% 0 to 5.0K | (93%) |
| 02-Nov-05 2:50 PM View: | Thompson J Stark Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 02-Nov-05 | Market Purchase | 1,500 | $3.98 | $5,970.00 | 26% 5.7K to 7.2K | (93%) |
| 25-Aug-05 11:14 AM View: | Dimmler Charles L III Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 24-Aug-05 | Market Purchase | 5,000 | $4.87 | $24,350.00 | 26% 18.9K to 23.9K | (95%) |
| 01-Aug-05 2:20 PM View: | Thompson J Stark Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 01-Aug-05 | Market Purchase | 1,100 | $4.90 | $5,390.00 | 24% 4.6K to 5.7K | (95%) |
| 07-Jun-05 4:24 PM View: | Gorry G Anthony Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 06-Jun-05 | Private Purchase | 10,000 | $0.15 | $1,500.00 | 100% 0 to 10.0K | |
| 27-May-05 12:24 PM View: | Thompson J Stark Phd Director | Ore Pharmaceutical Holdings... (ORXE.PK) | 26-May-05 | Market Purchase | 1,400 | $3.30 | $4,615.60 | 44% 3.2K to 4.6K | (92%) |
